Trials / Unknown
UnknownNCT06137209
Colonization of Skin by M. Luteus Q24 Probiotic
Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Serum in Healthy Adults
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- BLIS Technologies Limited · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the skin quality improvement and colonization efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the face from a serum format in healthy adults.
Detailed description
This is a randomized double-blind baseline controlled pilot study with no crossover for the assessment of any changes to the microbial make-up of the skin (The local skin microbiome), detection of colonization by the probiotic bacterium (BLIS Q24) on the skin and to evaluate the changes in skin quality parameters following topical application of probiotic in a serum format.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Active Comparator: Study Group A: Blis Q24 Serum at higher dose | Active Comparator: Study Group A: Blis Q24 Serum at 1e7 cfu/ dose (Active) |
| OTHER | Active Comparator: Study Group B: Blis Q24 Serum at lower dose | Active Comparator: Study Group B: Blis Q24 Serum at 1e6 cfu/ dose (Active) |
Timeline
- Start date
- 2023-10-02
- Primary completion
- 2023-11-22
- Completion
- 2024-03-15
- First posted
- 2023-11-18
- Last updated
- 2023-11-18
Locations
1 site across 1 country: New Zealand
Source: ClinicalTrials.gov record NCT06137209. Inclusion in this directory is not an endorsement.